Continuing the Conversation: FDA and CDC Leaders Discuss the COVID-19 Pandemic and Vaccines

COVID-19 Vaccines Update: FDA and CDC Leaders Address the Rare Disease CommunityПодробнее

COVID-19 Vaccines: Updates from the FDA and CDC (December 4, 2020)Подробнее

Stakeholder Call: COVID-19 Vaccine Update - 4/27/2021Подробнее

CDC, FDA discuss decision to pause use of J&J COVID-19 vaccineПодробнее

Joint Media Call: FDA & CDC to Discuss Janssen COVID-19 Vaccine - 4/13/2021Подробнее

FDA and CDC Virtual Press Conference: Johnson & Johnson COVID-19 Vaccine - 4/23/2021Подробнее

WATCH LIVE: FDA, CDC discuss J&J COVID vaccine issuesПодробнее

CDC, FDA lift pause on Johnson & Johnson COVID-19 vaccineПодробнее

COVID-19 Vaccine Approval and the FDAПодробнее

CDC committee meets to discuss allocating COVID-19 vaccine following the FDA's Pfizer approvalПодробнее

Coronavirus Vaccine Update From the CDC With Nancy MessonnierПодробнее

CDC, FDA discuss 'pause' on Johnson & Johnson COVID-19 vaccineПодробнее

CDC and FDA hold briefing on the Johnson & Johnson pauseПодробнее

FDA and CDC leaders explain why Johnson and Johnson vaccinations are pausingПодробнее

FDA and CDC to consider supporting annual COVID-19 vaccineПодробнее

WATCH LIVE: FDA, CDC experts answer questions about pause on Johnson & Johnson vaccineПодробнее

FDA and CDC recommend a 'pause' on Johnson & Johnson COVID-19 vaccine due to blood clot concernsПодробнее

FDA and CDC advisory panel approve third coronavirus vaccine for AmericansПодробнее

CDC and FDA recommend US pause use of Johnson & Johnson's COVID-19 vaccine over blood clot concernsПодробнее